07/01/2021
|
SHOP APOTHEKE EUROPE N.V. / Key word(s): Takeover/Mergers & Acquisitions NOT FOR DIRECT OR INDIRECT PUBLICATION, DISTRIBUTION OR RELEASE IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA AND JAPAN OR ANY JURISDICTION IN WHICH OFFERS OR SALES OF THE SECURITIES WOULD BE PROHIBITED BY APPLICABLE LAW. SHOP APOTHEKE EUROPE Acquires Digital Health Provider SMARTPATIENT.
Venlo, the Netherlands, 07 January 2021. Today, SHOP APOTHEKE EUROPE N.V. entered into a contract for the full acquisition of Munich-based SMARTPATIENT GmbH. The fast-growing and founder-managed company is one of the leading providers of digital health services. The MyTherapy app developed by SMARTPATIENT can be used with almost all chronic diseases and offers a range of services in the area of digital medication management. The acquisition of SMARTPATIENT enables SHOP APOTHEKE EUROPE to expand its technological expertise in the digital health services area even more rapidly. Both companies expect significant positive effects from the expanded service offering, especially in the Rx market segment. The parties have agreed not to disclose the exact purchasing price. In addition to an upfront cash component, the purchase price is comprised of three subsequent tranches, settled in part through shares of SHOP APOTHEKE EUROPE. The overall purchase price is in the upper double-digit million euro range. The founders and the current management team will continue to manage SMARTPATIENT's operations. Contact: rikutis consulting Thomas Schnorrenberg Cel: +49 151 46 53 13 17 E-Mail: presse@shop-apotheke.com Information and Explanation of the Issuer to this News: ABOUT SHOP APOTHEKE EUROPE. SHOP APOTHEKE EUROPE is one of the leading and fastest-growing online pharmacies in Continental Europe. With the acquisition of Europa Apotheek Venlo in November 2017, SHOP APOTHEKE EUROPE significantly extended its European market leadership. The product range for the whole family in the areas of OTC, beauty and personal care products as well as prescription drugs is supplemented by high quality natural food and health products, low carb products and sports nutrition following the acquisition of nu3 GmbH in July 2018. SHOP APOTHEKE EUROPE operates online pharmacies in Germany, Austria, France, Belgium, Italy, the Netherlands and Switzerland at this moment. SHOP APOTHEKE EUROPE delivers a broad range of more than 100,000 original products to over 5.9 million active customers (at the end of Q3 2020) fast and at attractive prices. In addition, SHOP APOTHEKE EUROPE provides comprehensive pharmaceutical consulting services. SHOP APOTHEKE EUROPE N.V. has been listed on the regulated market of the Frankfurt Stock Exchange (Prime Standard) since 13 October 2016 and has moved up to the MDAX index on 21 September 2020.
PRESS CONTACTS. Trade and popular media: Financial media: Investor relations: Thomas Schnorrenberg This publication constitutes an advertisement. This announcement does not constitute an offer for sale or a solicitation of an offer to purchase securities of SHOP APOTHEKE EUROPE N.V. in any jurisdiction. It does not constitute a securities prospectus. A public offer of securities of SHOP APOTHEKE EUROPE N.V. is not taking place. Statements contained herein could constitute so-called 'forward-looking statements'. Forward-looking statements can be recognized by words such as 'might,' 'will,' 'should,' 'plans,' 'anticipates,' 'anticipates,' 'estimates,' 'believes,' 'intends,' 'aims,' 'aim' or their negative form or corresponding modifications and comparable terms. Forward-looking statements are based on current expectations and involve a number of known and unknown risks, uncertainties and other factors that could cause the actual results, levels of utilization, developments and achievements of the group or industry in which it operates to be materially different than those contained herein or implied. There should be no undue reliance on forward-looking statements. The group will not update or revise any forward-looking statements contained herein, whether as a result of new information, future events or otherwise.
07-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | SHOP APOTHEKE EUROPE N.V. |
| Dirk Hartogweg 14 | |
| 5928 LV Venlo | |
| Netherlands | |
| Phone: | 0800 - 200 800 300 |
| Fax: | 0800 - 90 70 90 20 |
| E-mail: | carmen.herkenrath@shop-apotheke.com |
| Internet: | www.shop-apotheke-europe.com |
| ISIN: | NL0012044747, DE000A19Y072 |
| WKN: | A2AR94, A19Y07 |
| Indices: | MDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1158929 |
| End of Announcement | DGAP News Service |
|
|
1158929 07-Jan-2021 CET/CEST
